Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2020 - 12 - 17    symbols : Amgn    save search

FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
AMGN | News | $273.19 0.47% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.99% C: 0.93%

fda approval fda approval biosimilar
Amgen Awards Two Local Biotech Start-Ups With Golden Ticket To LabCentral
Published: 2020-12-17 (Crawled : 22:00) - biospace.com/
AMGN | News | $273.19 0.47% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.99% C: 0.93%

biotech awards
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

MTC | $2.28 46.15% 2.6M twitter stocktwits trandingview |
Technology Services

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology

OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance

MLEC | $1.865 33.21% 2.4M twitter stocktwits trandingview |
n/a

CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing

PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.